Skip to main content
Log in

Treatment of acute intracerebral hemorrhage with ɛ-aminocaproic acid

A pilot study

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Introduction: Up to 40% of primary intracerebral hemorrhages (ICHs) expand within the first 24 hours (natural history). The authors aimed to study the safety and preliminary efficacy of ɛ-aminocaproic acid (EACA) in halting ICH enlargement.

Methods: Consecutive patients with hematoma volumes ranging from 5 to 80 mL were recruited within 12 hours of ICH onset. A total of 5 g EACA was infused during 1 hour and then 1 g/hour for 23 hours. Hematoma volume was compared onbaseline, and 24–48-hour brain imaging. Consecutive untreated patients underwent the same imaging protocol.

Results: Three of the first five patients treated had HE>33% of their baseline volume. HE occurred in two of the nine untreated patients. The 80% confidence interval for HE in the treated patients was 32–88%. No thrombotic or other serious adverse events were attributed to EACA.

Conclusion: It is unlikely that the rate of HE in patients given EACA within 12 hours of ICH is less than the natural history rate, although this treatment appears to be safe.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28:1–5.

    PubMed  CAS  Google Scholar 

  2. Hanel RA, Xavier AR, Mohammad Y, Kirmani JF, Yahia AM, Qureshi, AI. Outcome following intracerebral hemorrhage and subarachnoid hemorrhage. Neurol. Res. 2002;24(Suppl 1): S58-S62.

    Article  PubMed  Google Scholar 

  3. Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC. Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology 2001;56:1294–1299.

    PubMed  CAS  Google Scholar 

  4. Lisk DR, Pasteur W, Rhoades H, Putnam RD, Grotta, JC. Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation. Neurology 1994;44:133–139.

    PubMed  CAS  Google Scholar 

  5. Kassell NF, Torner JC, Adams HP, Jr. Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage: preliminary observations from the Cooperative Aneurysm Study. J. Neurosurg. 1984;61:225–230.

    Article  PubMed  CAS  Google Scholar 

  6. Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volume. Stroke 1996;27:1304–1305.

    PubMed  CAS  Google Scholar 

  7. Mayer SA. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke 2003;34:224–229.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James C. Grotta MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piriyawat, P., Morgenstern, L.B., Yawn, D.H. et al. Treatment of acute intracerebral hemorrhage with ɛ-aminocaproic acid. Neurocrit Care 1, 47–51 (2004). https://doi.org/10.1385/NCC:1:1:47

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/NCC:1:1:47

Key Words

Navigation